| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.003 |